Early initiation of sodium-glucose linked transporter inhibitors (SGLT-2i) and associated metabolic and electrolyte outcomes in diabetic kidney transplant recipients.

Saved in:
Bibliographic Details
Title: Early initiation of sodium-glucose linked transporter inhibitors (SGLT-2i) and associated metabolic and electrolyte outcomes in diabetic kidney transplant recipients.
Authors: Song CC; Hume-Lee Transplant Center, Virginia Commonwealth University Health, Richmond, VA, USA., Brown A; Hume-Lee Transplant Center, Virginia Commonwealth University Health, Richmond, VA, USA., Winstead R; Hume-Lee Transplant Center, Virginia Commonwealth University Health, Richmond, VA, USA., Yakubu I; Hume-Lee Transplant Center, Virginia Commonwealth University Health, Richmond, VA, USA., Demehin M; Hume-Lee Transplant Center, Virginia Commonwealth University Health, Richmond, VA, USA., Kumar D; Hume-Lee Transplant Center, Virginia Commonwealth University Health, Richmond, VA, USA., Gupta G; Hume-Lee Transplant Center, Virginia Commonwealth University Health, Richmond, VA, USA.
Source: Endocrinology, diabetes & metabolism [Endocrinol Diabetes Metab] 2020 Sep 13; Vol. 4 (2), pp. e00185. Date of Electronic Publication: 2020 Sep 13 (Print Publication: 2021).
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: John Wiley & Sons Ltd Country of Publication: England NLM ID: 101732442 Publication Model: eCollection Cited Medium: Internet ISSN: 2398-9238 (Electronic) Linking ISSN: 23989238 NLM ISO Abbreviation: Endocrinol Diabetes Metab Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2398-9238
DOI:10.1002/edm2.185